Zymot
  • Patients
  • Healthcare Professionals
    • FAQs
    • Resources & Training
    • Publications
  • Devices
    • ZyMōt Multi (850uL) Sperm Separation Device
    • ZyMōt Multi (3mL) Sperm Separation Device
  • About Us
    • Management Team
    • Board of Directors
    • Scientific Affairs Team
    • Clinical Advisory Board
  • Contact Us

Category: Patient outcome

CAN A SPERM SELECTION TECHNIQUE IMPROVE EMBRYO PLOIDY?

02 Mar 2023

MICROFLUIDIC PREPARATION OF SPERMATOZOA FOR ICSI PRODUCES SIMILAR EMBRYO QUALITY TO DENSITY-GRADIENT CENTRIFUGATION: A PRAGMATIC, RANDOMIZED CONTROLLED TRIAL

02 Mar 2023

OPTIMIZING SPERM SELECTION AND REPRODUCTIVE OUTCOMES BY MICROFLUIDICS FOR COUPLES WITH RAISED DFI

25 Sep 2022

MALE AGE IS ASSOCIATED WITH SPERM DNA INTEGRITY: SELECTION OF HIGH DNA INTEGRITY SPERM BY MICROFLUIDICS SORTING IS CRITICAL TO CLINICAL OUTCOMES IN OLDER PATIENTS

25 Sep 2022

A TREATMENT APPROACH FOR COUPLES WITH DISRUPTED SPERM DNA INTEGRITY AND RECURRENT ART FAILURE

20 Jan 2022

LABORATORY AND CLINICAL OUTCOMES OF SPERMATOZA PREPARED THROUGH A MICROFLUIDIC DEVICE: A PROSPECTIVE PILOT SIBLING OOCYTE STUDY

01 Jan 2022

A THERAPEUTIC APPROACH FOR COUPLES WITH COMPROMISED SPERM DNA INTEGRITY AND A HISTORY OF ANEUPLOID EMBRYOS

01 Jan 2022

EUPLOIDY RATES AND PREGNANCY OUTCOMES USING THE ZYMOT DEVICE FOR SPERM PREPARATION

01 Jan 2022

ICSI OUTCOMES USING SPERMATOZOA WITH OPTIMAL GENOMIC INTEGRITY

01 Jan 2022

UTILIZING SPERMATOZOA WITH THE HIGHEST GENOMIC INTEGRITY ENHANCES ICSI OUTCOME.

01 Jan 2022

401 Professional Drive, Suite 130
Gaithersburg, MD USA 20879-3429

linkedin icon
facebook icon
instagram icon
youtube icon
twitter icon

Devices

  • ZyMōt Multi (850µL) Sperm Separation Device
  • ZyMōt Multi (3mL) Sperm Separation Device

Where to Find Us

  • USA
  • International

Contact Us

  • info@zymotfertility.com

© 2023 DxNow, Inc. All rights reserved.

Privacy Policy Legal Disclaimer